Microbiome Market Set To Grow From $0.93 Billion In 2026 To $1.64 Billion By 2030 At A CAGR Of 15%
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Microbiome Market Forecast: What Market Value Is Expected By 2030?
The microbiome market has experienced notable expansion over recent years, with projections indicating a rise from $0.82 billion in 2025 to $0.94 billion in 2026, reflecting a compound annual growth rate (CAGR) of 14.8%. This historical growth has been largely driven by heightened public awareness regarding gut health, a surge in research funding dedicated to microbiome studies, increased consumption of probiotics, significant advancements in sequencing technologies, and strategic collaborations forged between research institutions and biotechnology companies.
The microbiome market is projected to experience significant expansion in the coming years, with its value expected to reach $1.64 billion by 2030, driven by a compound annual growth rate (CAGR) of 15.0%. This growth during the forecast period is fueled by the incorporation of artificial intelligence into microbiome analysis, the growing embrace of personalized medicine, the development of therapies centered on the microbiome, the escalating incidence of chronic diseases, and the heightened consumer appetite for functional foods and supplements. Key developments shaping the market outlook include the emergence of customized microbiome-based treatments, innovations in probiotics and prebiotics, progress in diagnostic tools for the microbiome, deeper investigation into the gut-brain axis, and enhanced methods for integrating and interpreting microbiome data.
Download A Free Sample Report For Comprehensive Market Insights:
Microbiome Market Opportunity Drivers: What Is Creating New Revenue Potential?
The ongoing increase in healthcare spending is set to accelerate the expansion of the microbiome market in the coming years. Healthcare expenditure is defined as the overall sum of money allocated to medical services, related products, and associated activities within a particular healthcare system or economy over a specified timeframe. Such spending plays a crucial part in driving the microbiome market forward. With greater financial commitments to microbiome research and development, combined with growing public understanding of the microbiome’s role in human health, the need for microbiome-centered therapies and products is rising. For example, in December 2024, the Centers for Medicare & Medicaid Services, a U.S. agency overseeing Medicare and Medicaid, reported that American healthcare outlays grew by 7.5% in 2023, reaching $4.9 trillion—roughly $14,570 per person. Consequently, the upward trend in healthcare expenditures is fueling the growth of the complicated skin and skin structure infections drugs market.
Microbiome Market Segmentation: How Is The Market Structured Across Key Categories?
The microbiome market covered in this report is segmented –
1) By Microbe Category: Bacteria, Archaea, Viruses, Other Microbiomes
2) By Product: Therapeutics, Diagnostics
3) By Technology: Genomics, Proteomics, Metabolomics
4) By End-Use: Infectious Diseases, Gastrointestinal Disorders, Metabolic Disorders, Cancers, Other Diseases
Subsegments:
1) By Bacteria: Probiotic Bacteria, Pathogenic Bacteria, Environmental Bacteria, Bacterial Communities In Various Ecosystems
2) By Archaea: Methanogens, Halophiles, Acidophiles, Other Extremophiles
3) By Viruses: Bacteriophages, Eukaryotic Viruses, Environmental Viruses
4) By Other Microbiomes: Fungi, Protists, Helminths, Mycobiome
Microbiome Market Innovation Trends Driving Future Development
Key players in the microbiome industry are prioritizing advancements like personalized health insights, designed to empower users by delivering customized reports that pinpoint particular health issues. Personalized health insights involve data-driven, tailored information and suggestions based on an individual’s unique health profile. For example, in September 2024, Redcliffe Labs, a medical and diagnostic laboratory firm based in India, introduced its Gut Microbiome and HealthEx tests, aiming to improve preventive healthcare through customized health insights. These two specialized health assessments are intended to bolster preventive care. The gut microbiome test examines gut health, delivering findings on immune function, metabolism, and mental well-being. Meanwhile, an advanced blood test analyzes DNA to identify possible health risks linked to lifestyle, diet, and genetics. Together, these tests offer personalized guidance to support individuals in managing their overall health.
Microbiome Market Competitive Landscape And Leading Companies
Major companies operating in the microbiome market are Seres Therapeutics, Enterome Bioscience, Ferring Pharmaceuticals, Vedanta BioSciences, Second Genome Inc., Microbiotica, Rebiotix Inc, Locus Biosciences, Osel Inc., Xbiome Co. Ltd, Microba Life Sciences, Biome Australia, Shoreline Biome, BugSpeaks, Atlas Biomed, BiomX Ltd, ImmuneBiotech Medical Sweden AB, MetaboGen AB, Viome, PharmaBiome, NCCR Microbiomes, MaaT Pharma, Eligo Bioscience, T3 Pharmaceuticals, MicroBiome Therapeutics LLC, OpenBiome, Microbiome Insights Inc., Lallemand Health Solutions, Mybiotics Pharma, DayTwo, Next Biosciences, ViThera Pharmaceuticals Inc., Inqaba Biotechnical Industries (Pty), SNIPR Biome, MyBiome
Access The Complete Microbiome Market Report:
Microbiome Market Regional Analysis: Which Region Leads By Revenue?
North America was the largest region in the microbiome market in 2025. The regions covered in the microbiome market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
